Our medical team develops product development and registration strategies based on the project characteristics. Our goal is to achieve differentiated deployment and highly efficient clinical development in China and globally. We actively communicate with China NMPA, US FDA and other drug regulatory agencies during the clinical process to ensure the high standards of studies and obtaining approval.